Thus, this paper reviews the role of PGK1, the molecular mechanisms underlying PGK1 expression and activity in cancer, and the prospects for the use of PGK1 as a new diagnostic biomarker and therapeutic target in cancer and drug resistance. The gene discussed is PGK1; the disease is cancer.